Breaking News
FLASH SALE 0
FLASH SALE: Get 50% off InvestingPro | Stop guessing, start investing
Claim Sale
Close

Indivior PLC (2IVB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.8000 0.0000    0.00%
09/05 - Delayed Data. Currency in EUR
  • Volume: 0
  • Bid/Ask: 9.8000 / 9.9500
  • Day's Range: 9.8000 - 9.9000
Type:  Equity
Market:  Germany
ISIN:  GB00BN4HT335 
S/N:  A3DWFC
Indivior 9.8000 0.0000 0.00%

Indivior Company Profile

 
Read the Indivior company profile to learn more about the business and the management team. View Indivior PLC facts about how many employees Indivior has, INDV company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

1041

Equity Type

ORD

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Contact Information

Address 10710 Midlothian Turnpike Suite 125
North Chesterfield, 23235
United States
Phone 804 379 1090
Fax -

Top Executives

Name Age Since Title
Mark Crossley - 2014 CEO & Executive Director
Joanna Susan Le Couilliard 62 2021 Independent Non-Executive Director
Mark P. Stejbach 62 2021 Independent Non-Executive Director
David E. Wheadon 66 2024 Independent Non-Executive Chairman
Juliet Thompson 59 2021 Lead Independent Director
Peter James Jonathan Bains 68 2019 Independent Non-Executive Director
Barbara A. Ryan 65 2022 Independent Non-Executive Director
Daniel A. Ninivaggi 60 2025 Independent Non-Executive Director
Keith Humphreys 58 2023 Independent Non-Executive Director
Joseph J. Ciaffoni 53 2024 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Indivior (INDV) Price Discussion

Write your thoughts about Indivior PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Justin Langshaw
Justin Langshaw Oct 10, 2022 8:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone know what's happened here?
Al Al
Al Al Jul 10, 2020 18:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What a poor business. Extrodinary debt. No cash.
Glauco Pazzaglini
Glauco Pazzaglini Jul 10, 2020 18:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
totally agree. this is the crazy stock.
Kevin Heng
Kevin Heng Apr 10, 2019 13:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
potential 3 bln fines in US. company is broke.
Tariq Khan
Tariq Khan Apr 10, 2019 13:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
company tried settlement but rejected.the previous parent company has already set aside 400 million.
Tariq Khan
Tariq Khan Apr 10, 2019 9:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any ideas
Tariq Khan
Tariq Khan Apr 10, 2019 9:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
where this will stop
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email